Channing Capital Management, LLC Biogen Inc. Transaction History

Channing Capital Management, LLC

$3.76 Billion
Q3 2024

A detailed history of Channing Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Channing Capital Management, LLC holds 36,974 shares of BIIB stock, worth $5.55 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

36,974

Previous 37,665 1.83%

Holding current value

$5.55 Million

Previous $8.73 Million 17.91%

% of portfolio

0.19%

Previous 0.25%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $130,647 - $163,628	-691 Reduced 1.83%	36,974 $7.17 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $140,603 - $174,699	-738 Reduced 1.92%	37,665 $8.73 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $911,686 - $1.15 Million	4,300 Added 12.61%	38,403 $8.28 Million
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $907,499 - $1.09 Million	4,077 Added 13.58%	34,103 $8.82 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $7.61 Million - $8.58 Million	30,026 New	30,026 $7.72 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $7.78 Million - $10.2 Million	-26,500 Closed	0 $0
Q2 2018 Jul 20, 2018	SELL	$257.52 - $306.91 $960,292 - $1.14 Million	-3,729 Reduced 12.34%	26,500 $7.69 Million
Q1 2018 Apr 24, 2018	BUY	$260.13 - $367.91 $1.16 Million - $1.64 Million	4,468 Added 17.34%	30,229 $8.28 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $307 - $344	1 Added 0.0%	25,761 $8.21 Million
Q3 2017 Oct 31, 2017	BUY	$281.15 - $329.69 $7.24 Million - $8.49 Million	25,760	25,760 $8.07 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.

Account

Channing Capital Management, LLC Biogen Inc. Transaction History